AETHLON MEDICAL INC
Financial highlights
| Metric | FY March 31, 2025 | FY March 31, 2024 | FY March 31, 2023 | FY March 31, 2022 | FY March 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $574,245 | $294,165 | $659,104 |
| Operating income | -$9.3M | -$12.6M | -$11.9M | -$10.4M | -$7.9M |
| Operating expenses | $9.3M | $12.6M | $12.5M | $10.7M | $8.6M |
| Cash from operations | -$7.6M | -$10.1M | -$10.5M | -$9.8M | -$6.8M |
| Capital expenditure | $0 | $250,867 | $943,109 | $349,193 | $59,881 |
| Free cash flow | -$7.6M | -$10.4M | -$11.4M | -$10.1M | -$6.8M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $7.4M | $8.2M | $17.5M | $19.4M | $10.7M |
| Total liabilities | $2.2M | $2.5M | $2.4M | $2.4M | $1.4M |
Shares outstanding 1.3M · Free float 90.6%
Annual filing data through FY ended March 31, 2025; float as of July 3, 2026.